Sunriser® DPI

Sunriser® is a patented high-performance capsule-based dry powder inhaler capable of delivering up to 50 mg per dose with >50% lung delivery performance. Developed by Hovione in partnership with H&T Presspart, Sunriser® features a unique capsule movement that enables best-in-class delivery efficiency both with classic carrier-based and with spray-dried engineered formulations.

Sunriser® is developed for indications where chronic or medium-term treatments require high drug loads including the delivery of challenging cohesive and sensitive materials, with maximum efficiency.

Sunriser® offers a portable patient-friendly inhaler solution and is available for Licensing and Supply.

Applications

Asthma
COPD
CF
IPF
Antibiotics for lung infection
Analgesic drugs
Pulmonary hypertension drugs

Designed for maximum efficiency in Dry Powder Inhalation delivery

The demand for inhalable drugs that require high drug loads and the delivery of cohesive and sensitive materials has increased, making it necessary to develop more efficient delivery solutions. To address these challenges, the Sunriser® incorporates a unique flow path through the device, which combined with high-performance capsule dynamics, drives maximum efficiency in the dispersion and deagglomeration of inhalable dry powder formulations. Sunriser’s patented innovative engine delivers >50% to the lung consistently across flow rates and across formulation types.

Sunriser® is designed to overcome patient usability challenges promoting adherence and compliance with easy capsule loading, audio feedback and a transparent capsule chamber for visual checking that the complete dose has been inhaled from the capsule. It provides classical piercing with two needles and operates with size 3 capsules. Connectivity and digital features can be integrated.

In addition to Sunriser® device supply, Hovione can provide all formulation development services and capsule filling for targeted lung and systemic indications. Hovione can conduct fully integrated device and formulation development and optimization of generic and innovator drug products, from proof-of-concept to clinical manufacturing and commercial drug product supply.

Available for Partnering and Supply

Multi-use capsule-based dry powder inhaler
High-performance, fine particle fraction > 50% across flow rates with both carrier-based and spray-dried engineered formulations
Patent life up to 2038
Easy-to-use: open and load, close and inhale
Audio feedback to the patient
Highly portable and convenient
Classical capsule piercing with two needles
Operates with Size 3 capsules
Transparent capsule chamber for dose feedback to patient
Dose up to 50 mg
Medium device resistance
Color and branding customization available
Connectivity and digital features can be integrated
Available for Licensing, Supply and integrated Formulation-Device development